Showing results (201-210 of 250) with videos related to
Sort By:
Pageof 25
Cancer Cell|November 19, 2019
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate TumorsParisa Mazrooei, Ken J Kron, Yanyun Zhu, et al.Oncotarget|July 21, 2016
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort studyPedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer ClinicGirish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2023
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancerMichael J Dubec, David L Buckley, Michael Berks, et al.Plos One|April 1, 2015
Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancersLorin Dodbiba, Jennifer Teichman, Andrew Fleet, et al.Nature Communications|September 24, 2017
Mitochondrial mutations drive prostate cancer aggressionJulia F Hopkins, Veronica Y Sabelnykova, Joachim Weischenfeldt, et al.European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.The Lancet. Oncology|May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation OncologyRobert G Bristow, Brian Alexander, Michael Baumann, et al.Journal of the National Cancer Institute|January 7, 2023
A polygenic two-hit hypothesis for prostate cancerKathleen E Houlahan, Julie Livingstone, Natalie S Fox, et al.Plos Medicine|August 16, 2020
Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validationAndrée-Anne Grosset, Frédérick Dallaire, Tien Nguyen, et al.Pageof 25